Kronox Lab Sciences Ltd

Kronox Lab Sciences Ltd, a player in the Specialty Chemicals sector, has reached an all-time low in its stock price, reflecting a sustained period of underperformance relative to market benchmarks and sector peers. The stock closed just 2.38% above its 52-week low of ₹129, underscoring the severity of its recent decline.

Kronox Lab Sciences Ltd, a player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.129, marking a significant decline amid broader market movements. The stock’s recent performance reflects a continuation of downward momentum, with key valuation and growth metrics contributing to its current standing.

Kronox Lab Sciences Ltd, a player in the Specialty Chemicals sector, has recorded a new all-time low of Rs.129 on 09 Jan 2026, marking a significant milestone in its recent market trajectory. The stock’s decline reflects a continuation of subdued performance trends amid broader sector and market movements.

Kronox Lab Sciences Ltd, a specialty chemicals company, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite modest short-term gains, the stock’s overall outlook has deteriorated, reflected in a downgrade from Hold to Sell by MarketsMOJO on 7 October 2025. This article analyses the recent price movements, technical indicators, and broader market context to provide a comprehensive view of Kronox Lab’s current positioning.

Kronox Lab Sciences Ltd, a player in the Specialty Chemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators reveal a mixed outlook that investors should carefully analyse.

Kronox Lab Sciences Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 October 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 02 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Kronox Lab, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in key analytical parameters. This adjustment follows a period marked by subdued financial trends, valuation concerns, and technical indicators signalling caution for investors.

Kronox Lab Sciences, a player in the Specialty Chemicals sector, recorded a new 52-week low of Rs.129.95 today, marking a significant price level for the stock amid a broader market environment where the Sensex opened lower and small caps showed relative strength.

Kronox Lab Sciences, a player in the Specialty Chemicals sector, recorded a new 52-week and all-time low of ₹129.95 today, marking a significant milestone in its recent market trajectory. This development comes amid a series of declines over the past year, reflecting ongoing challenges in both short-term and long-term performance metrics.

Kronox Lab, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment comes amid subdued stock performance and valuation concerns, highlighting the challenges faced by the company in maintaining investor confidence.

Kronox Lab Sciences Ltd., a micro-cap specialty chemicals manufacturer, reported a modest quarter in Q2 FY26, with net profit rising to ₹6.68 crores—a sequential increase of 6.37% quarter-on-quarter (QoQ) and 3.24% year-on-year (YoY). With a market capitalisation of ₹546.91 crores, the Ahmedabad-based company continues to demonstrate operational resilience through strong margins, yet faces headwinds from tepid revenue growth and an increasingly bearish market sentiment. The stock closed at ₹147.40 on November 12, 2025, down 0.84% on the day, reflecting investor caution following the results announcement.

Kronox Lab Sciences, a microcap in the specialty chemicals sector, has experienced stock price fluctuations and bearish technical indicators. The company has underperformed against the Sensex over various timeframes, reflecting challenges in aligning with broader market trends and indicating a potential need for strategic adjustments.